Your browser doesn't support javascript.
loading
GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol.
Sukhtankar, Devki D; Fung, Juan José; Kim, Mi-Na; Cayton, Thomas; Chiou, Valerie; Caculitan, Niña G; Zalicki, Piotr; Kim, Sujeong; Jo, Yoonjung; Kim, SoHui; Lee, Jae Min; Choi, Junhee; Mun, SeongGyeong; Chin, Ashley; Jang, Yongdae; Lee, Ji Yeong; Kim, Gowoon; Kim, Eun Hee; Huh, Won-Ki; Jeong, Jae-Yeon; Seen, Dong-Seung; Cardarelli, Pina M.
Afiliación
  • Sukhtankar DD; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
  • Fung JJ; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
  • Kim MN; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Cayton T; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
  • Chiou V; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
  • Caculitan NG; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
  • Zalicki P; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
  • Kim S; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Jo Y; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Kim S; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Lee JM; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Choi J; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Mun S; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Chin A; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
  • Jang Y; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Lee JY; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Kim G; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Kim EH; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Huh WK; School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
  • Jeong JY; Institute of Microbiology, Seoul National University, Seoul, Republic of Korea.
  • Seen DS; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
  • Cardarelli PM; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea.
PLoS One ; 18(10): e0287863, 2023.
Article en En | MEDLINE | ID: mdl-37878624
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Compuestos Heterocíclicos / Mieloma Múltiple Límite: Animals Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Compuestos Heterocíclicos / Mieloma Múltiple Límite: Animals Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos